Niagen Bioscience, Inc. Common Stock NAGE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $6.32M+52.9% | $4.13M-9.7% | $4.58M+26.8% | $3.61M-28.7% | $5.06M-29.5% | ||
| $116K-16.5% | $139K-11.5% | $157K-0.6% | $158K0.0% | $158K+4.6% | ||
| $1.72M-1.8% | $1.75M-0.5% | $1.76M+18.0% | $1.49M+38.4% | $1.08M+43.0% | ||
| -$1.19M-276% | $679K-81.6% | $3.69M+195% | $1.25M-84.1% | $7.88M-8.2% | ||
| $5.25M+5,293% | -$101K-321% | -$24K+82.2% | -$135K-322% | -$32K+53.6% | ||
| $2.35M— | —— | —— | —— | $0— | ||
| -$2.29M— | $0-100% | $148K-96.0% | $3.74M+20.5% | $3.11M-17.2% | ||
| $1.76M+254% | $498K-86.9% | $3.82M-21.4% | $4.86M-55.7% | $10.96M-10.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Niagen Bioscience, Inc. Common Stock generate?
- Niagen Bioscience, Inc. Common Stock (NAGE) generated $4.4M in operating cash flow over the trailing twelve months.
- Where does Niagen Bioscience, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Niagen Bioscience, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
